[Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
D000328:Adult; D000437:Alcoholism; D001201:Ascites / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D004232:Diuretics / Q000494:pharmacology / Q000627:therapeutic use*; D004487:Edema / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology* / Q000652:urine; D008875:Middle Aged; D009318:Natriuresis / Q000187:drug effects; D011188:Potassium / Q000097:blood / Q000652:urine; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use*; D013268:Stimulation, Chemical; D014223:Triamterene / Q000494:pharmacology / Q000627:therapeutic use
D004232:Diuretics; D013148:Spironolactone; D011188:Potassium; D014223:Triamterene
Traitement des oedémes cirrhotiques par le triamtéréne, l'amiloride et la spirolactone. Nouveaux faits cliniques et biologiques.